Grip strength
Assessment of the genetic predisposition to lower hand grip strength, one of the main clinical indicators of sarcopenia.
MyPrevention Sarcopenia is a muscle genetic test that analyzes genetic variants involved in characterizing sarcopenia, making it possible to personalize prevention and treatment guidelines.
Sarcopenia is a disease associated with ageing, characterized by the accelerated loss of muscle mass and function. It is influenced by both genetic factors and lifestyle, and can even develop in middle-aged people.
Knowing the genetics related to this disease makes it possible to personalize prevention guidelines and appropriate treatment for each person.
Sarcopenia can be influenced by the weakening of muscle capacities. The test assesses the genetic predisposition to alterations in the main indicators of muscle health.
Assessment of the genetic predisposition to lower hand grip strength, one of the main clinical indicators of sarcopenia.
Analysis of genetic variants associated with a lower percentage of muscle mass, a determining factor in disease progression.
The genetic predisposition to alterations in muscle strength and mass, in turn, increases the predisposition to developing sarcopenia.
The report provides the specialist with genetic information of clinical value to identify at-risk patients and personalize prevention and treatment strategies.
A simple, non-invasive process designed to fit into clinical practice.
The user receives instructions to correctly collect the sample.
DNA is obtained through a saliva sample, painlessly and non-invasively.
The sample is processed to analyze genetic variants involved in sarcopenia.
The report details the genetic predisposition to sarcopenia and associated muscle factors.
It is recommended for specialists whose patients show symptoms associated with sarcopenia, related to muscle mass loss and weakness, or have a family history.
Early detection of the genetic predisposition to muscle loss associated with ageing.
Identification of genetic factors that influence muscle mass and grip strength.
A preventive tool for patients with a family history or symptoms of muscle weakness.
Sarcopenia is a disease associated with ageing, characterized by the accelerated loss of muscle mass and function. It is influenced by both genetic factors and lifestyle, and can even affect middle-aged people.
The test analyzes genetic variants involved in characterizing sarcopenia, including factors associated with grip strength and muscle mass percentage, which are the main clinical indicators of this disease.
The sample is obtained non-invasively through saliva. It is painless and suitable for anyone of any age.
No. Genetics doesn’t change throughout life. The analysis is performed only once and the results remain valid permanently.
Once the sample is received at the lab, results are available within a maximum of 20 business days.
For people with symptoms of muscle mass loss or weakness, with a family history of sarcopenia, or as a prevention tool for specialists in geriatrics, sports medicine and primary care.
Contact our team for more information about MyPrevention Sarcopenia or to request a genetic study.